SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A breakout to fresh 52-week highs ahead of the Q3 report is drawing attention, with traders focused on BRIUMVIs sales growth and possible guidance updates. Buyout and short-squeeze theories are circulating but remain speculation; the upcoming subcutaneous BRIUMVI data is another anticipated catalyst, while some traders warn the rally may already reflect high expectations.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Berkshires disclosed accumulation of a large Lennar stake has fueled bargain-buying interest, but traders are debating it against Hunterbrooks short-report allegations about Lennars transactions with spinoff Millrose. The dispute adds to concerns over weak results and outlook, pressured affordability, and elevated mortgage rates.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is drawing attention after traders cited a Northland upgrade tied to its C3 Code agentic-AI platform, alongside heavy call activity and the stocks potential as a short-squeeze candidate. Bullish traders see a turnaround opportunity, while skeptics point to declining revenue and persistent losses as reasons for caution.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave shares are drawing attention amid a steep selloff across quantum-computing stocks, with traders questioning whether high valuations, limited near-term commercialization and competition from classical AI can support the sector ahead of Q3 results. Some see the pullback as a buying opportunity, while others expect more downside.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results, led by Dupixent and Eylea HD, drove a sharp share-price jump and a fresh high. Traders largely welcomed the report, while debating whether the breakout can hold and pointing to heavy call-option activity.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

Discussion centers on REalloys speculative role in a North American rare-earth and magnet supply chain ahead of 2027 U.S. defense sourcing restrictions, including its Army-linked Tooele opportunity and Tanbreez offtake agreement. Bulls point to strategic demand and potential sector momentum, while skeptics cite limited company updates, execution risk and sharp volatility; the Tooele discussions are not presented as a finalized agreement.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLAs quarterly results topped expectations and its forward outlook was strong, but shares have sold off amid broader semiconductor weakness and analyst price-target cuts. Traders are divided between viewing the decline as an overreaction and buying opportunity, and worrying that the stocks downtrend and valuation pressure may persist.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

BLZE is under pressure after a steep pullback, with traders pointing to broader tech weakness and CoreWeaves decline while positioning around the upcoming earnings report. The community is split between dip-buyers betting on strong results or new contracts and cautious traders concerned that earnings could bring further losses.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is falling amid a broad semiconductor selloff that traders attribute largely to Intels weak forward guidance, with some also pointing to bearish put-option activity. The community is split between buying the pullback and expecting further downside, while noting the drop appears tied more to sector pressure than a clear Qualcomm-specific catalyst.

BitGo Holdings, Inc. operates as a digital asset infrastructure company delivering custody, wallets, staking, trading, financing, stablecoins, and settlement services from regulated cold storage. It focuses on accelerating the transition of the financial system to a digital asset economy. The company was founded by Michael Belshe and Ben Davenport in 2013 and is headquartered in Sioux Falls, SD.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGos latest earnings are drawing attention: traders are weighing strong revenue growth against a wider net loss, with some blaming the results for renewed share-price weakness. Bullish investors argue that Bitcoins recovery and expanding custody and institutional services could support a rebound, while others remain concerned about profitability and the stocks persistent decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Beyond Air (XAIR) Q1 2027 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Beyond Air (XAIR) Q4 2026 Earnings Call Transcript

Transcript: Beyond Air Q4 2026 Earnings Conference Call

On Friday, Beyond Air (NASDAQ:XAIR) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below.
This content is powered by Benzinga APIs. For comprehensive financial dataread more...

Earnings Scheduled For June 26, 2026

Companies Reporting Before The Bell
 Beyond Air (NASDAQ:XAIR) is estimated to report quarterly loss at $0.56 per share on revenue of $2.30 million.
 Apogee Enterprises (NASDAQ:APOG) is expected to report quarterlyread more...

Stock Market Today: Dow Jones Inches Up, S&P 500 And Nasdaq Futures Slip As Tech Selloff Gathers Pace Apple, Beyond Air In Focus

U.S. stock futures mixed on Friday, Nasdaq 100 & S&P 500 down, Dow Jones up. Macro data shows strong PCE Index & revised Q1 GDP.read more...

Lucid, Beyond Air, Conagra Stocks Hit 52-Week Lows: What's Behind The Drag?

Equity

Fresh analyst cuts, delisting fears, and leadership uncertainty pushed all three stocks to 52-week lows despite pockets of retail optimism.


At $150 off, the new MacBook Air is now cheaper than last year's model

Both the 13-inch and 15-inch MacBook Airs are down to new low prices. | Photo: Antonio G. Di Benedetto / The Verge If you were bummed that the new M5-powered MacBook Air cost $100 more than last...

Beyond Air XAIR Q3 2026 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Beyond Air Earnings Preview

XAIR Stock More Than Doubled Today — What’s Driving The Rally?

Beyond Air said that IP portfolio company XTL will acquire 85% of its subsidiary NeuroNOS.


Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air, Beyond Cancer segments, and NeuroNos. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.

Beyond Air Inc

Bullish Sentiment

<ul class="summary-bullets"><li>Lucid fell to a new low after weak revenue guidance, a $300 million stock offering, and multiple analyst price target cuts.</li><li>Beyond Air hit a fresh low after receiving a Nasdaq warning over its sub-$1 share price.</li><li>Conagra Brands slid after naming a new CEO, with analysts warning several macroeconomic factors could keep earnings under pressure.</li></ul>Shares of Lucid Group, Beyond Air, and Conagra Brands each hit fresh 52-week intraday lows on Wednesday, driven by distinct catalysts. XAIR continued its slide in overnight trading, while LCID and CAG managed to pare some of their regular session losses.<h1 class="st-heading-1">Why LCID Hit A 52-Week Low</h1>Lucid has been in the headlines all week:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-lucid-stock-rising-new-ceo-strategy/cZJtIR5RIvu">naming</a> a new CEO, securing fresh funding from Saudi Arabia's sovereign wealth fund, and inking a robotaxi partnership with Uber. But investor sentiment has soured on the back of a significantly weaker-than-expected revenue outlook for the current quarter and a $300 million stock offering. The EV maker has yet to turn a profit, nearly 19 years after its founding.Wednesday brought a fresh round of price target cuts. Baird lowered its target to $12 from $14, maintaining a 'Neutral' rating, citing the new CEO appointment and the Uber partnership as reasons to update its model. TD Cowen analyst Itay Michaeli cut his target more sharply, to $10 from $19, while keeping a 'Hold' rating.Despite the pressure, Stocktwits sentiment for&nbsp;<a href="https://stocktwits.com/symbol/LCID">LCID</a> was 'extremely bullish' at the last close, suggesting retail traders are betting on a near-term turnaround following the leadership shakeup. The stock hit an intraday 52-week low of $8.11 on Wednesday and is down over 25% year-to-date.<h1 class="st-heading-1">Why XAIR Hit A 52-Week Low</h1>Beyond Air disclosed on Wednesday that it had received a Nasdaq notice for non-compliance with the $1.00 minimum bid price requirement and has requested a hearing before the Nasdaq Hearings Panel, scheduled for May 14, 2026. Any delisting or suspension is stayed pending the panel's written decision, meaning shares are expected to remain listed until the panel issues its decision. However, there is no assurance that the panel will grant continued listing or that compliance will be regained.The Nasdaq notice compounds a difficult stretch for the medical device and biopharmaceutical company. Last month, CEO Steve Lisi resigned, effective March 27, and the board appointed chief commercial officer Robert Goodman as his replacement. Earlier in March, the company also confirmed that its proposed transaction with XTL Biopharmaceuticals involving Beyond Air's NeuroNOS subsidiary had been terminated after the parties failed to reach a definitive agreement.On Stocktwits, sentiment for&nbsp;<a href="https://stocktwits.com/symbol/XAIR">XAIR</a> was 'bullish' at the last close, with several retail traders predicting the stock will avoid delisting. XAIR hit an intraday 52-week low of $0.43 on Wednesday and has shed 28% year to date.<h1 class="st-heading-1">Why CAG Hit A 52-Week Low</h1>Conagra shares have been sliding since Monday, when the packaged food giant&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/cag-stock-crashes-to-near-17-year-lows/cZJ85DBRIun">named</a> a new CEO, less than a month after cutting its annual profit forecast amid mounting uncertainty around global trade. The market's initial read on the leadership change has not been encouraging.JPMorgan analysts described the incoming CEO as well-regarded and knowledgeable, but they still expect earnings pressure to build over the coming quarters as Conagra continues to wrestle with inflationary headwinds in freight and packaging. Jefferies echoed that view, noting that the new CEO's near-term options are limited given the company's high leverage, margin pressures, and exposure to inflation.Retail traders on Stocktwits were 'bullish' on&nbsp;<a href="https://stocktwits.com/symbol/CAG">CAG</a> at the last close, with sentiment partly lifted by news that two directors purchased over $700,000 in shares. The stock hit an intraday 52-week low of $14.04 on Wednesday and has shed nearly 19% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dow-sp500-nasdaq-futures-trump-us-iran-war-near-end-hims-msft-rum-nflx-xndu/cZJvTEVRIwu">Dow, S&amp;P 500, Nasdaq Futures Rise After Trump Says US-Iran War ‘Very Close To Over</a>

Lucid, Beyond Air, and Conagra hit new 52-week lows, but retail sentiment remains bullish for at least two stocks. | Representative image: Getty Images

Fresh analyst cuts, delisting fears, and leadership uncertainty pushed all three stocks to 52-week lows despite pockets of retail optimism.

Conagra Brands Inc

Lucid Group Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.24
Prev Close	$2.31
Open	$2.28
Dividend Yield	0.00%
50-Day Moving Average	$3.04
Beta	0.85
Avg. Volume	103,118.41
PE Ratio	-0.03

52-Week High	$53.20
52-Week Low	$2.05
Market Capitalization	$3.73M
EPS (Annual)	-$80.11
Price to Book	0.83
Revenue Per Employee	$142,203.70

Feed

News

Sentiment

Earnings

Fundamentals

Info

XAIR Fundamentals